Inventing type biotechs by nature run in the red. They have Venture Capitalists that keep them afloat. With the Venture money harder to get HLCS was one of the few that survived the recession. Now they have the equipment out commercially and beginning to provide research results. In the coming weeks the collaberation with Correlegan diagnostics and their Heart Assay findings using Helicos will be out. That will change how we treat the Number One Killer of Americans and put Helicos on the front page of all medical related mags.